Oncopharmpod
To Rechallenge, Or Not To Rechallenge
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:14:32
- Mas informaciones
Informações:
Sinopsis
Weighing the risks & benefits of immunotherapy rechallenge in patients with a prior immune-related adverse event (irAE). Reference: https://www.ncbi.nlm.nih.gov/pubmed/31461381
